Stock CGON CG ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. CG Oncology, Inc.

Equities

CGON

US1569441009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-28 pm EDT 		5-day change 1st Jan Change
32.43 USD -0.86% Intraday chart for CG Oncology, Inc. +11.94% 0.00%
May. 24 Sector Update: Health Care Stocks Softer in Friday Afternoon Trading MT
May. 24 CG Oncology Shares Jump After Potential Combination Therapy for Bladder Cancer Meets Phase 2 Primary Endpoint MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Goldman Sachs Upgrades CG Oncology to Buy From Neutral With $50 Price Target
MT
Cantor Fitzgerald Starts Coverage on CG Oncology With Overweight Rating, $75 Price Target
MT
Goldman Sachs Initiates Coverage on CG Oncology With Neutral Rating, $42 Price Target
MT
Morgan Stanley Initiates CG Oncology With Overweight Rating, Price Target is $55
MT
HC Wainwright Starts Coverage on CG Oncology With Buy Rating, $75 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CGON Stock
  4. News CG Oncology, Inc.
  5. Analyst Reco.